Mushrooms Inc. (OTCPK: MSRM)
Health Care · Pharmaceuticals · US
$0.02
+8.16% today · -27.4% 1Y
Mushrooms Inc. (OTCPK: MSRM) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $685.41K and employs 6 people.
Over the last twelve months the share price has lost 27.4%, trading between 0.01 and 0.04.
Tweenvest scores Mushrooms Inc. across four factors: quality 8/100, value 44/100. Its strongest factor is value.
MSRM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $685.41K
- Revenue (TTM)
- $47.99K
- P/E
- —
- EPS
- -7.29
- Dividend yield
- —
- Beta (5Y)
- 1.51
- 52-week high
- $0.04
- 52-week low
- $0.01
- Avg volume (3M)
- —
- Shares outstanding
- 44.94M
- Employees
- 6
- Next earnings
- —
About Mushrooms Inc.
Mushrooms, Inc. is a biotechnology company that develops products from mushrooms and mycelium. The company focuses on mycelium's industrial applications for carbon-neutral products, health supplements, and technologies for healthcare and textiles, such as bacterial detection and nutrient delivery. The company was formerly known as Marijuana Strategic Ventures Inc. and changed its name to Mushrooms Inc. in October 2022. [20, 22, 28, 33]
- ISIN
- US56782M1071
- Founded
- 2002
- Listed since
- Nov 20, 2006
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,190.02 | -3.54% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.56 | -0.94% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.39 | -1.96% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.39 | -0.65% |
Figures last refreshed Aug 18, 2026.